Quantum dots (QDs) are colloidal semiconductor nanocrystals which have unique optical properties due to their three dimensional quantum confinement regime. The quantum confinement may be explained as follows: in a semiconductor bulk material the valence and conduction band are separated by a band gap (Eg). After light absorption, an electron (
In this way, QDs can be defined as colloidal particles made of semiconductor materials with diameters ranging typically from 2 to 10 nm. The semiconductor particle (named “core”) is usually coated by a layer of another semiconductor material (named “shell”) which in general has a greater band gap than the band gap of the core rendering excellent optical properties. The QDs’ core is responsible for the fundamental optical properties (i.e. light absorption and emission) and the shell is used to passivate the surface of the core with the goal to improve its optical properties and reduce chemical attack. The shell separates physically the optically active core from its surrounding medium (Dabbousi et al., 1997; Santos et al., 2008a) as depicted in Figure 1. As a consequence, the nanoparticles’ optical properties become less sensitivity to changes induced, for example, by the presence of oxygen or pH in the local environment. At the same time, the shell reduces the number of surface dangling bonds, which can act as trap states for electrons and minimize the QDs fluorescence efficiency.
For biomedical purposes, in which fluorescence in the visible region is usually required, both core and shell are composed of elements from the II B and VI A groups of the Periodic Table. The major examples are CdSe/ZnS, CdTe/CdS and ZnSe/ZnS QDs (Dabbousi et al., 1997; Santos et al., 2008a). Most QDs crystallize either in the cubic zinc blend or in the hexagonal wurtzite type structure (Yeh et al., 1992).
In nanosized regime many QDs’ physico-chemical properties are different from those of the same bulk materials. Since QDs are fluorescent nanoparticles, an example of these changes is the shift of the emission color according to the particle size. In this case, QDs made from the same material, but with different sizes, can present fluorescence light emission in different spectral regions (from the ultraviolet to the infrared light) as represented in Figure 2. This is a consequence of QDs energy level discretization and also of the QDs band gap energy changes according to their size. After absorption, electrons come back to valence band and QDs emission is proportional to the band gap energy. As smaller the QDs are, the higher is the band gap energy and more towards to the blue end is the emission (since the energy is inversely proportional to the wavelength of the light).
Another observed feature for these systems is that the QDs’ absorption bands are broad and extend up to the UV region, as observed in Figure 3 (A). The first peak (located at greater wavelength) represents an exciton formed by transitions between discrete states. The width of the first absorption band is related to the size dispersion of the nanoparticles and can give us information about the QDs’ average size and nanoparticles concentration (Santos et al., 2008a). On the other hand, the width of the emission spectrum is related to the presence of crystal defects which result in discreet electronic states between the conduction and the valence band. These new electronic states displace the emission towards to the red and broaden the emission band and is related to the passivation shell.
The QDs’ physico-chemical properties have offered considerable advantages and complementary characteristics over the conventional fluorescent dyes. Besides the size tunable emission discussed before, compared to organic fluorophores, the major advantages offered by QDs are:
A broad absorption band (Fig. 3A), allowing a flexible cross section for multiphoton microscopy and as well as for Fluorescence Energy Transfer (FRET) processes (Fig. 3A and B compare the characteristic absorption and emission band profiles of QDs and organic fluorophores).
An active surface for chemical conjugation. QDs can be conjugated to a variety of proteins or antibodies and become inorganic-biological hybrids nanoparticles that combine characteristics of both materials, that is, the fluorescence properties of QDs with the biochemical functions of the attached biomolecules (Fig. 1).
High resistance to photobleaching: the most important advantage of QDs over organic dyes allowing long term observation of these fluorescent nano-probes.
Colloidal QDs can be synthesized in organic or aqueous medium. When compared to organometallic routes, water-based QDs syntheses are cheaper, less toxic and intrinsically biocompatible to applications in biomedical fields (Santos et al., 2008a). The colloidal synthesis generally involves several consecutive stages: (i) nucleation from an initially homogeneous solution, (ii) growth of the preformed crystal nuclei into isolated particles, reaching the desired size from the reaction mixture and (iii) post preparative treatments, such as colloidal purification, size precipitation and UV light exposure.
During the colloidal synthesis QDs end up coated by organic or inorganic molecules (called surfactants or stabilizers), which keep the nanocrystals away from each other preventing agglomeration and precipitation (Brus, 1984; Santos et al., 2008a) (Figure 1). In some cases, as for CdTe QDs for example, the surfactant molecules may also act as precursors of the passivation shell (Menezes et al., 2005). For the direct aqueous synthetic procedures the main classes of organic molecules used as surfactants are alkyl-thiol molecules such as mercaptopropionic acid - MPA, mercaptoacetic acid - MAA and mercaptosuccinic acid – MSA, Dihydrolipoic acid – DHLA, cysteine – CYS, cysteamine – CYSAM and different mercaptodithiols. The carboxyl, thiol or amine terminals of these molecules can be used as chemical bridges to conjugate biomolecules (such as proteins and biopolymers) which confer more specificity for biological applications. The chemical binding of such biomolecules to the surface of the QDs is a process defined as bioconjugation. It can be accomplished by simple adsorption (of stabilizing agent such as: MPA, MSA or cysteine) to the biomolecule or by covalent attachment. Currently, bioconjugation occurs between carboxyl-amine (through EDC and Sulfo-NHS) groups, amine-amine (by glutaraldehyde), disulfide bonds and streptavidin-biotin interactions (Goldman et al., 2002).
For the non-aqueous synthetic routes, nucleation and growth of QDs occur in the solution phase in the presence of organic surfactant molecules, which dynamically adhere to the surface of growing crystals. Typical surfactants include long-chain carboxylic and phosphonic acids (e.g., oleic acid and
2. Applications of quantum dots in biomedical sciences
Since the first mention in the literature, in 1998, QDs have been studied extensively and the applications of these fluorescent nanocrystals range from imaging fixed and live cells all the way to fluoroimmunoassays rendering innovative diagnostic methodologies (Bruchez Jr.
2.1. Quantum dots as fluorophores for imaging and detection purposes
2.1.1. Non-specific labeling
The staining of a biological sample can occur even when the reporting probe is not designed to interact with a specific molecule. Untargeted labeling of the probe with the (biological) material is defined as a
In the past years, when the use of QDs in biomedical research was still at the beginning, passive labeling (simple staining of biological samples) was of great interest since researchers aimed to study the probe itself as a potential dye. In such applications, labeling could give information about bioavailability and more importantly about the optical properties of these nanoparticles in biological conditions. It has been shown that the simple incubation with a biological specimen may have the potential to stain it, revealing its structural features or even their biological behavior. We observed this feature for instance in the non-targeted glutaraldehyde-capped CdS/Cd(OH)2 QDs staining of different neural cell lines, normal and cancerous cells (Santos et al., 2008b) as demonstrated in the staining pattern observed in Figure 4 (A – D). For these systems the unrestricted labeling/internalization allows the identification of minor details of the cellular architecture, such as cell-cell contacts, axons and intracellular organelles, as shown on the images of Fig. 4A and
Fig. 4B. Moreover, these QDs are taken up at different rates depending on cellular stage as for normal glial or glioblastoma cells (Farias et al., 2006) – Figures 4C and 4D, respectively. Therefore, passive labeling can be a useful strategy when one aims to label the whole biological sample or to study differences in the behavior of normal
2.1.2. Internalization of quantum dots by live cells
In general, the binding of non-targeted particles with living cells results in internalization of the particles. This process may be accomplished by different routes, which depend either on the particle properties (size, shape, surface functionalization, surface charge and the combination of these properties) or on the cell type (i.e. lineage, metabolic state, cell cycle stage, normal or cancerous cells). The first assumption was that the main internalization process resulted from endocytosis. One of the first reports to show that internalization of these nanoparticles occurs by endocytosis was described by Jaiswal et al. (Jaiswal et al., 2003)
Molecule specific endocytosis is known as receptor-mediated endocytosis which are clathrin or caveolae-mediated endocytosis, or clathrin/caveolae independent endocytosis. It is probably the major pathway where QDs are uptaken by cells. It seems that lipid rafts localized within the plasma membrane plays an important role in the QDs uptake as well. These rafts provide a support for the assembly of many receptors, adaptors as well as proteins involved in a signaling complex such as caveolae and clathrin. (Nichols, 2003a; Nichols 2003b)
In 2011, Maysinger and collaborators synthesized QDs with almost the same hydrodynamic size (between 8-10 nm) and functionalized with different short ligands such as cysteine, cysteamine, dihydrolipoic acid and mercaptopropionic acid (Al-Hajaj et al, 2011). These QDs were tested in human embryonic kidney cells (Hek 293) and human heptocellular carcinoma cells (Hep G2) in order to achieve information about these QDs uptake and elimination. They showed that most of the QDs with the same size but different surface properties were uptaken through lipid raft-mediated endocytosis with the contribution of the XAG transport system (responsible for the carrier-mediated Na(+)-independent transport of anionic amino acids such as glutamate and aspartate across the plasma membrane of cells) which takes up cysteine, glutamate and aspartate. The contribution of a P-glycoprotein transporter on QD efflux was also demonstrated during the experiments. Figure 5 shows the hypotheses about QDs internalization and elimination.
These results corroborated with those obtained from Chan’s (Jiang et al., 2008), where they showed the size dependent internalization of particles using both pathways clathrin- and caveolae- mediated endocytosis. It has been shown that particles with a diameter of d = 40 - 50 nm are endocytosed more efficiently than those larger or smaller (Jiang et al., 2008). Sizes also dictates the final location of the particles (i.e. cytosol, nucleus), being able or not to cross their natural cellular barriers (Williams et al., 2009), which is on the other hand cell-type dependent (Williams et al., 2009).
However, QDs internalization by cells not only depends on their size. Although size is an important parameter, charge is thought as one of the most important parameter controlling cell-QD interactions (Conroy et al., 2008). An interesting finding of charge-mediated internalization and interactions with intracellular structures was found by Conroy et. al. (Conroy et al., 2008), who demonstrated that these carboxyl-coated (negative) QDs but not amine-coated (positive) are able to enter macrophage-like cells and bound nuclear structures rich in the positive histone proteins. In fact, such interactions were sufficiently strong to change QDs’ optical and colloidal properties even in cell-free conditions (Conroy et al., 2008).
2.1.3. Some examples of specific labeling
The capacity of QDs for specific labeling cells and tissues depends on the bioconjugation. Santos
Con-A was used also in another work for cellular labeling of
In another work of the same group it was also used CdS/Cd(OH)2 QDs functionalized with glutaraldehyde as efficient fluorescent labels for living human red blood cells (Santos et al., 2008a), the aim of this investigation was to determine the antigen-A expression in subgroups of group A erythrocytes.
2.1.4. Quantum dots for intracellular delivery
QDs can be used as a probe for monitoring protein dynamics in live cells, allowing the study of their traffic down to a single molecule (Pinaud et al., 2010), taking advantages of the most striking properties as a fluorescent probe, which is long term imaging for prolonged periods of time (Courty et al., 2006). However, traffic of molecular dynamics, especially in live cells, are almost exclusively carried out for surface molecules – membrane proteins, accessible by the external side of the cells. This limitation arise mainly due to the incapacity of water dispersed QDs to cross the lipid bilayers by simple diffusion (only few works report tracking of intracellular molecules) (Chen & Gerion, 2004).
The physical methods to deliver aqueous compounds into cells are of special interest since the precise control over the cell (extent of delivery over the population) and the amount of materials can be reached in most cases. These are mainly based on microinjection and electroporation. In fact these two traditional and well recognized methods are among the most efficient methods to deliver QDs into cells. The electroporation is based on the application of one or more strong electrical pulses, which is thought to create localized pores in the membrane bilayer for enhancing its permeability – Figure 9A. Using electroporation, Chen and Gerion delivered QDs into HeLa cells (Chen & Gerion, 2004). The QDs were able to be recognized by the cellular machinery and enter the cell nucleus in living cells, although in a fraction of the total number of cells and as agglomerated particles. In fact, nanoparticle aggregates of up to 500 nm have been reported to be produced later after the application of electric pulses, even for protein-conjugated QDs. However, if agglomeration does not matter, as in the case of simple cell labeling, electroporation can be well suited. In fact, cells filled with QDs after electroporation can be readily seen in living mice for cell tracking purposes (Yoo et al., 2010).
Figure 9 shows schematic representations of the most common strategies for intracellular delivery of membrane-impermeable materials. Figure 9A and B represent physical processes while Fig. 9C and D are chemical methods. In electroporation, cells are exposed to an electric field and a single or multiple pulses are applied, creating pores that allow the passage of materials to the cell interior. In the microinjection (Figure 9B), a micropipette delivers precise amounts of fluids inside any compartment of the cells. In Fig. 9C, the conjugation of QDs with Cell Penetrating Peptides (CPPs) (discussed later) can deliver them into cells by direct membrane entrance (as shown in the scheme of Figure 9C) or by endocytosis. Also by endocytosis, polycation-coated QDs (green spheres) trigger “proton-sponge effect”, (discussed later) releasing endo/lysosomal content into the cytosol. In Figure 9D, binding of negative cargos to lipoplex systems results in endocystosis likely due to charge interactions with negative plasma membrane. After internalization, charge neutralization seems to release the cargo from the lipid system.
Another physical method for intracellular delivery of membrane impermeable materials is microinjection. This technique is based on the insertion of precise volumes inside an aqueous compartment (such a cell) by micropipettes – Figure 9B. Since the first attempts of using QDs as fluorescent probes, microinjection is recognized as a potent method to insert these particles in intracellular media. One example of the application of microinjection it is the use of micelle-capped QDs as an agent to follow the development of tissues derived from a single cell in living
Although their recognized efficiency, both methods suffer from some drawbacks. Electroporation not only cause QDs to aggregate, but may seriously compromise cellular viability. On the other hand, microinjection is technically and costly demanding, requiring specialized equipment and, as a serial technique it has poor statistical significance.
Chemical approaches represent a wealthy range of strategies for intracellular delivery of membrane impermeable materials, and include covering cargos’ surface or couple/bind them to a vehicle, promoting the labels enter into cytoplasm of a large number of cells simultaneously in a straightforward way. Moreover, it can actually be used in living animals - the methods described above can only be used in such applications in very specific conditions.
Many methods to allow QDs to reach the cell cytosol are based on the conjugation of surface of nanoparticles to interact or to be recognized by cells until they reach the cytoplasm by different means. One of the most effective chemical methods for nanoparticle delivery into cells is the conjugation with Cell Penetrating Peptides (CPPs). A number of publications report such a class of molecules for this purpose, in which the mechanism of cell entry is similar to endocytosis (Thorén
A wide range of molecules can be conjugated to QDs’ surface to be specifically delivered to cells (toxins, sugars, polymers and so on); however most of them lead to receptor-mediated endocytosis, which predominantly result in entrapment into endocytic vesicles. For this reason, we will not address here intracellular delivery of QDs by molecules which do not explicitly release these particles freely in cytosol.
Other chemical modifications can result in intracellular release after nanoparticle endocytosis rather than simple membrane permeation – as proposed for CPPs. One of such approaches is to cover QDs’ surface with osmotic active polymers such as polyethyleneimine. After endocytosis, such polycations are capable of sequestering protons by H+-pumps in the endo/lysosomal membrane, which in turn force the entrance of Cl- ions and water to balance osmotic effects (this is the reason why this approach is called the “proton-sponge effect”). As a consequence, it leads vesicle rupture and releases endocytosed materials into the cell cytosol. Using this approach, Yezhelyev
Quantum dots encapsulation
Quantum Dots can be entrapped in a vehicle for its delivery instead of being conjugated to transporter molecules, a strategy that can be also suited for intracellular delivery after endocytic uptake. It is quite advantageous because it allows the conjugation of targeting moieties (i.e. antibodies, ligands) on the surface of the nanoparticles, which was otherwise occupied by the targeting transporter molecules (as in the case of CPPs peptides and polymers). Moreover, it can avoid the rupture of acidic intracellular vesicles, which has the tendency to cause cytotoxicity effects. The encapsulating vehicles can be classified in two major groups, named polymeric and lipid delivering systems. QDs were encapsulated in functionalized polymeric poly(lactic-co-glycolic acid) (PLGA) nanospheres and delivered into the cell cytosol after endocytosis of the complex (Kim et al., 2008). After preferential endocytosis of antibody-coated polymer nanospheres into ErbB2 over expressing cancer cells, the polymer were degraded in the acidic intracellular compartments releasing the bioconjugated QDs, which in turn could reach and label intracellular structures such as mitochondria and actin filaments.
Another approach is using micelles. An advantage of encapsulating QDs in lipid micelles relies on the small size of the resulting probe, up to 25 nm (Carion et al., 2007). Taking advantages on the physical-chemical and photostability of these QD-containing micelles, the group who reported this system for the first time could track cell lineage developments in live
Among the vehicles composed of lipids, probably the most popular is liposomes (Valenzuela, 2007; Al-Jamal & Kostarelos, 2007). Liposomes are lipid vesicles containing one (or more) lipid bilayer(s) enclosuring an aqueous compartment and that can entrap hydrophilic and/or hydrophobic materials during its formation (Valenzuela, 2007). As in the case of micelles (or any other encapsulation system), their interaction with biological species depends on the physical-chemical properties, which can be fine-tuned. In fact, Yang et al. (Yang et al., 2009) encapsulated water aqueous CdTe QDs in folate-conjugated liposomes and showed that these vesicles can be directed to folate-overexpressing cancer cells and be monitored by QDs fluorescence. The resulting system is resistant to optical and chemical degradation, with lower toxic effects.
QDs can also be delivered to cells by commercial cationic liposomes, the lipofection system (Fig. 9D). Lipoplex are positively-charged lipidic vesicles (mainly liposomes) able to bind negative particles, including oligonucleotides and QDs, which mediate charge interactions with cells, leading to endocytosis of the resulting system and eventually the release of cargos inside the cell. In such an application, Yoo et al. (Yoo et al., 2008) reported for the first time the use of these lipid vesicles as QD vehicles for protein tracking inside living cells. In contrast to earlier works, their bioconjugated QDs could escape from cellular vesicles and reach the cytosol, where they could be used to track the movements of actin, kinesin and tubulin proteins. Although the mechanism of endossomal release of materials delivered by cationic liposomes is not known, it is believed that charges play important roles in membrane destabilization, which could explain the successfully applications of such liposomes. However cytosolic release is not the main fate of delivered moieties in most applications of cationic liposomes, as exemplified above. It is important to note that lipofection delivery is not based on encapsulation; it is rather based on electrostatic interactions with negatively-charged cargos.
2.2. Quantum dots as probes in other bioassays
An increasing interest in using QDs as more than passive/active labels is reflected by the great number of published data in the literature in the past decade. There is a growing research community that recognizes that the fluorescent QDs may be extensively applied as a central component of nano-probes (Algar & Krull, 2008). We may classify among all the suggested applications the following: Fluorescence Resonance Energy Transfer (FRET) for bioassays, optical biosensors and Photodynamic Therapy (PDT).
In all these applications, the QDs act as scaffolds for the assembly of biomolecular probes while its fluorescence is modulated by biorecognition events. In the particular case of FRET-QDs studies, a broad absorption band combined with a size-tunable fluorescence and larger physical size (when compared to conventional dyes) allow: (i) optimization of the spectral overlap with any potential FRET acceptor; (ii) excitation at a wavelength far from the acceptor absorption peak (minimizing acceptor direct excitation); QDs can be excited over a range of wavelengths in the blue-ultraviolet region of the spectrum to allow minimization of the direct excitation of acceptors and (iii) the ability to assemble multiple acceptors around a QD core to increase the overall FRET efficiency (Algar & Krull, 2008; Bakalova et al., 2004; Juzenasa
The great potential of FRET-QDs applications may be exemplified by several reports. For instance, Stringer
QDs may also play a critical role as energy acceptors in bioluminescence resonance energy transfer (BRET) processes, with a bioluminescent protein as the energy donor. BRET resembles FRET in many aspects except that it does not require external light source for the donor excitation. The broad excitation spectra and large Stokes shift of QDs allow them to be excited by nearly all the bioluminescent proteins in BRET assemblies. Feasibility of QDs as the BRET acceptor for a mutant of Renilla luciferase (Luc8 with improved chemical stability and light efficiency) has been recently realized both
More recently QDs have also been applied in photodynamic therapy (PDT) related processes (Juzenasa
3. Some drawbacks of quantum dots
Non-specific interactions are a common phenomenon on the application of biological probes. Besides some benefits, these interactions are commonly a negative feature. An incomplete conjugation may result in residual non-conjugated QDs in the same colloidal suspension which can bind or interact non-specifically with the biological system and interfere in the desired results interfering in the specificity of the original applications.
The most common strategy to overcome non-specific labelling relies in covering the QDs surface with polar polymer molecules, such as polyethylene glycol (PEG). This is because such polymers are biologically “inert” and hinder electrostatic interactions of nanoparticle surface against cell surface or molecules in suspension Pegylated nanoparticles are therefore less prone to aggregation (that is, much more stable) and virtually binding-free. Moreover, they can allow further conjugation with functional biomolecules, include proteins and antibodies (Hezinger
Understanding the interactions of nanoparticles and biological specimens, specially cells, is of great interest since one can therefore modulate specific cellular processes. Unrestricted interactions of any kind of materials, including QDs, have the potential to be toxic, especially at higher concentration and/or with enhanced adsorption/internalization. Beyond the changes over cell function, more evident effects are prone to be caused by QDs, including cellular ones such: (i) changes in cell morphology (Chang et al., 2009), (ii) oxidative stress (Lovrić, et al., 2005), (iii) release of heavy metal compounds (Kirchner et al., 2005) and (iv) genetic and epigenetic damage (Choi et al., 2008), as well as local inflammation in live rats, as we have recently reported.
4. General conclusions
QDs have broad and strong one-photon absorption, narrow and symmetric size-tunable fluorescence bands, and a great resistance to photobleaching, making them an attractive alternative to molecular fluorophores in imaging applications and bioanalytical chemistry assays. This Chapter discusses some current applications of QDs as well as presents some drawbacks that still remain. Taken together, all these findings show that a deeper understanding of the mechanisms underlying QDs-biological systems interactions is helpful in the way that researchers can avoid side effects and improve the quality of labeling of QDs for diagnostics and therapeutic purposes.
The authors are grateful to CAPES, CNPq, FACEPE, HEMOPE, L’óreal, Brazilian Academy of Sciences and UNESCO. This work is also linked to the National Institute of Photonics (INCT-INFO). The authors also wish to thank Pedro Barroca for the schematic drawings.
Algar W. R. Krull U. J. 2008Quantum Dots as Donors in Fluorescence Resonance Energy Transfer for the Bioanalysis of Nucleic Acids, Proteins, and Other Biological Molecules. Anal. Bioanal. Chem., 391 1609 1618
Algar W. R. Tavares A. J. Krull U. J. 2010Beyond Labels: A Review of the Application of Quantum Dots as Integrated Components of Assays, Bioprobes, and Biosensors Utilizing Optical Transduction. Anal. Chim. Acta, 673 1 25
Al-Hajaj N. A. Moquin A. Neibert K. D. Soliman G. N. Winnik F. M. Maysinger D. 2011Short Ligands affect Modes of QD uptake and elimination in Human Cells. ACS Nano, 6 4909 4918
Al-Jamal W. T. Kostarelos K. 2007Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications. Nanomedicine, 2 85 98
Bakalova R. Ohba H. Zhelev Z. Ishikawa M. Baba Y. 2004Quantum dots as photosensitizers? Nature Biotechnology, 22 1360 1361
Biju V. Itoh T. Ishikawa M. 2010Delivering quantum dots to cells: bioconjugated quantum dots for targeted and nonspecific extracellular and intracellular imaging. Chem. Soc. Rev., 39 3031 3056
Brus L. E. 1984Electron-electron and electron-hole interactions in small semiconductor crystallites-the size dependence of the lowest excited electronic state. Journal of Chemical Physics, 80 4403 4409
Cai W. Shin D. W. Chen K. Gheysens O. Cao Q. Wang S. X. Gambhir Chen S. S. X. 2006Peptide-Labeled Near-Infrared Quantum Dots for Imaging Tumor Vasculature in Living Subjects. Nano Lett., 6 669 676
Carion O. Mahler B. Pons T. Dubertret B. 2007Synthesis, encapsulation, purification and coupling of single quantum dots in phospholipid micelles for their use in cellular and in vivo imaging. Nature Protocols, 2 2383 2390
Chang S. Q. Dai Y. D. Kang B. Hana W. Mao L. Chen D. 2009UV-enhanced cytotoxicity of thiol-capped CdTe quantum dots in human pancreatic carcinoma cells. Toxicology Letters, 188 104 111
Chaves C. R. Fontes A. Farias P. M. A. Santos B. S. Menezes F. D. Ferreira R. C. Cesar C. L. Galembeck A. Figueiredo R. C. B. Q. 2008Application of core-shell PEGylated CdS/Cd(OH)2 quantum dots as biolabels of Trypanosoma cruzi parasites. Applied Surface Science, 255 728 730
Chen F. Gerion D. 2004Fluorescent CdSe/ZnS Nanocrystal-Peptide Conjugates for Long-term, Nontoxic Imaging and Nuclear Targeting in Living Cells. Nano Letters, 4 1827 1832
Choi A. O. Brown S. E. Szyf M. Maysinger D. 2008Quantum dot-induced epigenetic and genotoxic changes in human breast cancer cells. J Mol Med, 86 291 302
Conroy J. Byrne S. J. Gun’ko Y. K. Rakovich Y. P. Donegan J. F. Davies A. Kelleher D. Volkov V. 2008CdTe Nanoparticles Display Tropism to Core Histones and Histone-Rich Cell Organelles. Small, 4 2006 2015
Courty S. Luccardini C. Bellaiche Y. Cappello G. Dahan M. 2006Tracking Individual Kinesin Motors in Living Cells Using Single Quantum-Dot Imaging. Nano Letters. 6 1491 1495
Dabbousi B. O. Rodriguez V. J. Mikulec F. V. Heine J. R. Mattoussi H. Ober R. 1997CdSe) ZnS core-shell quantum dots: synthesis and characterization of a size series of highly luminescent nanocrystallites. Journal of Physical Chemistry B, 101 9463 9475
Dubertret B. Skourides P. Norris D. J. Noireaux V. Brivanlou A. H. Libchaber A. 2002In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles. Science, 298 1759 1762
Farias P. M. A. Santos B. S. Menezes F. D. Ferreira R. Fontes A. Carvalho H. F. Romão L. Moura-Neto V. Amaral J. C. O. F. Cesar C. L. Figueiredo R. C. B. Q. Lorenzato F. R. B. 2006Quantum dots as fluorescent bio-labels in cancer diagnostic. Phys. Stat. Sol. (C), 3 4001 4008
Gao J. Chen X. Cheng Z. 2010Near-infrared quantum dots as optical probes for tumor imaging. Curr. Top Med Chem., 10 1147 1157
Ghinea N. Simionescu N. 1985Anionized and Cationized Hemeundecapeptides as Probes for Cell Surface Charge and Permeability Studies: Differentiated Labeling of Endothelial Plasmalemmal Vesicles. The Journal Of Cell Biology Volume, 100 606 612
Goldman E. R. Anderson G. P. Tran P. T. Mattoussi H. Charles P. T. Mauro J. M. 2002Conjugation of Luminescent Quantum Dots with Antibodies Using an Engineered Adaptor Protein To Provide New Reagents for Fluoroimmunoassays. Anal. Chem., 74 841 847
Jaiswal J. K. Matoussi H. Mauro J. M. Simon S. 2003Long-Term Multiple Color Imaging Of Live Cells Using Quantum Dot Bioconjugates. Nature Biotechnology, 21 47 51
Jiang W. Kim Y. Rutka S. B. J. T. Chan W. C. W. 2008Nanoparticle-mediated cellular response is size-dependent. Nature Nanotechnology, 3 145 150
Juzenas P. Chen W. Sun Y. P. Coelho M. A. N. Generalov R. Generalova N. Christensen I. L. 2008Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Advanced Drug Delivery Reviews, 60 1600 1614
Kato I. T. Santos C. C. Benetti E. Tenorio D. P. L. A. Cabral Filho. P. E. Sabino C. P. Fontes A. Santos B. S. Prates R. A. Ribeiro M. S. Cd Te. Cd-M S. quantum P. A. as dots fluorescent. probes to. label yeast. cells synthesis. characterization conjugation with. Concanavalin A. 2012Photonics West, San Francisco. Proceedings of SPIE- Colloidal Nanocrystals for Biomedical Applications VII, 8232 82320D
Kim B. Y. S. Jiang W. Oreopoulos J. Yip C. M. Rutka J. T. Chan W. C. W. 2008Biodegradable Quantum Dot Nanocomposites Enable Live Cell Labeling and Imaging of Cytoplasmic Targets. Nano Letters, 8 3887 3892
Kirchner C. Liedl T. Pellegrino S. K. T. Javier A. M. Gaub H. E. Stölzle S. Fertig N. Parak W. J. 2005Cytotoxicity of Colloidal CdSe and CdSe/ZnS Nanoparticles. Nano Letters, 5 331 338
Lira R. B. Cavalcanti M. B. Seabra M. A. B. L. Silva D. C. N. Amaral A. J. Santos B. S. Fontes A. 2012Non-specific interactions of CdTe/Cds Quantum Dots with human blood mononuclear cells. Micron, 43 621 626
Liu W. Howarth M. Greytak A. B. Zheng Y. Nocera D. G. Ting A. Y. Bawendi M. G. 2008Compact Biocompatible Quantum Dots Functionalized for Cellular Imaging. J. Am. Chem. Soc., 130 1274 1284
Liu W. Zhang S. Wang L. Qu C. Zhang C. Hong L. Yuan L. Huang Z. Wang Z. Liu S. Jiang G. 2011CdSe Quantum Dot (QD)-Induced Morphological and Functional Impairments to Liver in Mice. PLoS ONE, 6e24406. doi:10.1371/journal.pone.0024406.
Lovrić J. Bazzi H. S. Cuie Y. Fortin G. R. A. Winnik F. M. Maysinger D. 2005Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J Mol Med, 83 377 385
Ma -Hock L. Brill S. Wohlleben W. Farias P. M. A. Chaves C. R. Tenório D. P. L. A. Fontes A. Santos B. S. Landsiedel R. Strauss V. Treumann S. van Ravenzwaay B. 2012Short term inhalation toxicity of a liquid aerosol of CdS/Cd(OH)2 core shell quantum dots in male Wistar rats. Toxicology Letters, 208 115 124
Phys. Chem. Chem. Phys., Medintz I. L. Mattoussi H. (20 Quantum-Based Dot. Resonance Energy. Transfer Its Growing. Application in. Biology 11 17 45
Medintz I. L. Uyeda T. H. Goldman E. R. Mattoussi H. 2005Quantum dot bioconjugates for imaging, labelling and sensing. Nature Materials, 4 435 446
Menezes F. D. de Brasil Jr A. G. Moreira W. L. Barbosa L. C. Cesar C. L. Ferreira R. C. de Farias P. M. A. de Santos B. S. 2005CdTe/CdS core shell quantum dots for photonic applications, Microelectronics Journal, 36 989 991
Nelson S. R. Ali M. Y. Trybus K. M. Warshaw D. M. 2009Random walk of processive, quantum dot-labeled myosin Va molecules within the actin cortex of COS-7 cells. Biophys J., 97 509 518
Nichols B. J. 2003aCaveosomes and endocytosis of lipid rafts. J. Cell Sci., 116 4707 4714
Nichols B. J. 2003bGM1-containing lipid rafts are depleted within clathrin-coated pits. Curr. Biol., 13 686 690
Noh Y. W. Lim Y. T. Chung B. H. 2008Noninvasive imaging of dendritic cell migration into lymph nodes using near-infrared fluorescent semiconductor nanocrystals. The FASEB Journal, 22 3908 3918
Pinaud F. Clarke S. Sittner A. Dahan M. 2010Probing cellular events, one quantum dot at a time. Nature Methods, 7 275 285
Pyo D. Yoo J. 2012New Trends in Fluorescence Immunochromatography. J. Immunoassay and Immunochemistry, 33 203 222
Rieger S. Kulkarni R. P. Darcy D. Fraser S. E. Koster R. W. 2005Quantum Dots Are Powerful Multipurpose Vital Labeling Agents in Zebrafish Embryos. Developmental Dynamics, 234 670 681
Samia A. C. S. Dayal S. Clemens B. 2006Quantum Dot-based Energy Transfer: Perspectives and Potential for Applications in Photodynamic Therapy. Photochemistry and Photobiology, 82 617 625
Semiconductor Quantum Dots for Biological Applications. In: Mohamed Henine (Editor Chefe). (Org.). Handbook of Self Assembled Semiconductor Nanostructures Novel Devices in Photonics and Electronics. Amsterdam: Elsevier, Santos B. S. Farias P. M. A. . Fontes A. 2008a 773 798
Santos B. S. Farias P. M. A. Menezes F. D. Brasil Jr A. G. Fontes A. Romão L. Amaral J. O. Moura-Neto V. Tenório D. P. L. A. Cesar C. L. Barbosa L. C. Ferreira R. 2008bNew highly fluorescent biolabels based on II-VI semiconductor hybrid organic-inorganic nanostructures for bioimaging. Applied Surface Science, 255 790 792
Santos B. S. Farias P. M. A. . Menezes F. D. . Ferreira R. C. Alves Junior. S. Figueiredo R. C. B. Q. Carvalho Junior. L. B. Beltrão E. I. C. 2006CdS-Cd(OH)2 core shell quantum dots functionalized with Concanavalin A lectin for recognition of mammary tumors. Physica Status Solidi. C, Conferences and Critical Reviews, 3 4017 4022
Stringer R. C. Hoehn D. Grant S. A. 2008Quantum Dot-Based Biosensor for Detection of Human Cardiac Troponin I Using a Liquid-Core Waveguide. Sensors Journal, IEEE, 8 295 300
Tekdas D. A. Durmus¸ M. Yanıka H. Ahsen V. 2012Photodynamic therapy potential of thiol-stabilized CdTe quantum dot-group 3Aphthalocyanine conjugates (QD-Pc) Spectrochim Acta Part A: Molecular and Biomolecular Spectroscopy, 93 313 320
Eds). Nanobiotechnology of biomimetic membranes,, New York: Springer, Valenzuela S. Liposome techniques. for synthesis. of biomimetic. lipid membranes. in Ferrari. M. Martin D. . 75 87
Verma A. Stellacci F. 2010Effect of Surface Properties on Nanoparticle-Cell Interactions. Small, 6 12 21
Williams Y. Sukhanova A. Nowostawska M. Davies A. M. Mitchell S. Oleinikov V. Gun’ko Y. Nabiev I. Kelleher D. Volkov Y. 2009Probing Cell-Type-Specific Intracellular Nanoscale Barriers Using Size-Tuned Quantum Dots. Small, 5 2581 2588
Xia Z. Rao J. 2009Biosensing and imaging based on bioluminescence resonance energy transfer. Current Opinion in Biotechnology, 20 1 8
Yang C. Ding N. Xu Y. Qu X. Zhang J. Zhao C. Hong L. Lu Y. Xiang G. 2009Folate receptor-targeted quantum dot liposomes as fluorescence probes. Journal of Drug Targeting, 17 502 511
Yeh C. Y. Lu Z. W. Froyen S. Zunger A. 1992Zinc-blende-wurtzite polytypism in semiconductors. Physical Review B, 46 10086 10097
Yezhelyev M. V. Q. I. L. O’Regan R. M. Nie S. Gao X. 2008Proton-Sponge Coated Quantum Dots for siRNA Delivery and Intracellular Imaging. J. Am. Chem. Soc., 130 9006 9012
Yin Y. Alivisatos A. P. 2005Colloidal nanocrystal synthesis and the organic-inorganic interface. Nature, 437 664 670
Yoo J. S. Won N. Kim H. B. Bang J. Kim S. Ahn S. Soh K. S. 2010In vivo imaging of cancer cells with electroporation of quantum dots and multispectral imaging. Journal of Applied Physics, 107 124702 124710
Yoo J. Kambara T. Gonda K. Higuchi H. 2008Intracellular imaging of targeted proteins labeled with quantum dots. Experimental Cell Research, 314 3563 3569